Tibet Weixinkang Medicine Co., Ltd. (SHA:603676)

Tibet Weixinkang Medicine Revenue

Tibet Weixinkang Medicine had revenue of 276.24M CNY in the quarter ending September 30, 2025, a decrease of -23.50%. This brings the company's revenue in the last twelve months to 1.17B, down -6.97% year-over-year. In the year 2024, Tibet Weixinkang Medicine had annual revenue of 1.30B, down -1.69%.

• Revenue (ttm): 1.17B
• Revenue Growth: -6.97%
• P/S Ratio: 3.85
• Revenue / Employee: 1.70M
• Employees: 689
• Market Cap: 4.50B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.30B	-22.41M	-1.69%
Dec 31, 2023	1.32B	-75.89M	-5.43%
Dec 31, 2022	1.40B	364.92M	35.31%
Dec 31, 2021	1.03B	317.96M	44.43%
Dec 31, 2020	715.67M	-25.30M	-3.41%